These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
386 related articles for article (PubMed ID: 20506361)
1. Recombinant human cytochrome P450 monooxygenases for drug metabolite synthesis. Schroer K; Kittelmann M; Lütz S Biotechnol Bioeng; 2010 Aug; 106(5):699-706. PubMed ID: 20506361 [TBL] [Abstract][Full Text] [Related]
2. [Cytochrome P450 isoenzymes in metabolism of endo- and exogenic compounds]. Wiśniewska A; Mazerska Z Postepy Biochem; 2009; 55(3):259-71. PubMed ID: 19928582 [TBL] [Abstract][Full Text] [Related]
3. The bacterial P450 BM3: a prototype for a biocatalyst with human P450 activities. Yun CH; Kim KH; Kim DH; Jung HC; Pan JG Trends Biotechnol; 2007 Jul; 25(7):289-98. PubMed ID: 17532492 [TBL] [Abstract][Full Text] [Related]
4. Reconstitution premixes for assays using purified recombinant human cytochrome P450, NADPH-cytochrome P450 reductase, and cytochrome b5. Shaw PM; Hosea NA; Thompson DV; Lenius JM; Guengerich FP Arch Biochem Biophys; 1997 Dec; 348(1):107-15. PubMed ID: 9390180 [TBL] [Abstract][Full Text] [Related]
5. Application of drug metabolising mutants of cytochrome P450 BM3 (CYP102A1) as biocatalysts for the generation of reactive metabolites. Damsten MC; van Vugt-Lussenburg BM; Zeldenthuis T; de Vlieger JS; Commandeur JN; Vermeulen NP Chem Biol Interact; 2008 Jan; 171(1):96-107. PubMed ID: 17996858 [TBL] [Abstract][Full Text] [Related]
6. Structure-function of cytochromes P450 and flavin-containing monooxygenases: implications for drug metabolism. Halpert JR; Domanski TL; Adali O; Biagini CP; Cosme J; Dierks EA; Johnson EF; Jones JP; Ortiz de Montellano P; Philpot RM; Sibbesen O; Wyatt WK; Zheng Z Drug Metab Dispos; 1998 Dec; 26(12):1223-31. PubMed ID: 9860932 [TBL] [Abstract][Full Text] [Related]
7. Oxidation of 1,8-cineole, the monoterpene cyclic ether originated from eucalyptus polybractea, by cytochrome P450 3A enzymes in rat and human liver microsomes. Miyazawa M; Shindo M; Shimada T Drug Metab Dispos; 2001 Feb; 29(2):200-5. PubMed ID: 11159812 [TBL] [Abstract][Full Text] [Related]
8. Roles of cytochrome b5 in the oxidation of testosterone and nifedipine by recombinant cytochrome P450 3A4 and by human liver microsomes. Yamazaki H; Nakano M; Imai Y; Ueng YF; Guengerich FP; Shimada T Arch Biochem Biophys; 1996 Jan; 325(2):174-82. PubMed ID: 8561495 [TBL] [Abstract][Full Text] [Related]
9. [The role of drug metabolizing enzymes in the effect and side-effect of the drugs]. Vereczkey L; Jemnitz K; Monostory K; Veres Z; Kóbori L Orv Hetil; 2005 May; 146(19):947-52. PubMed ID: 15969306 [TBL] [Abstract][Full Text] [Related]
10. Characterization of microsomal cytochrome P450 enzymes involved in the oxidation of xenobiotic chemicals in human fetal liver and adult lungs. Shimada T; Yamazaki H; Mimura M; Wakamiya N; Ueng YF; Guengerich FP; Inui Y Drug Metab Dispos; 1996 May; 24(5):515-22. PubMed ID: 8723730 [TBL] [Abstract][Full Text] [Related]
11. Bufuralol hydroxylation by cytochrome P450 2D6 and 1A2 enzymes in human liver microsomes. Yamazaki H; Guo Z; Persmark M; Mimura M; Inoue K; Guengerich FP; Shimada T Mol Pharmacol; 1994 Sep; 46(3):568-77. PubMed ID: 7935340 [TBL] [Abstract][Full Text] [Related]
12. A novel cytochrome P450 mono-oxygenase from Streptomyces platensis resembles activities of human drug metabolizing P450s. Worsch A; Eggimann FK; Girhard M; von Bühler CJ; Tieves F; Czaja R; Vogel A; Grumaz C; Sohn K; Lütz S; Kittelmann M; Urlacher VB Biotechnol Bioeng; 2018 Sep; 115(9):2156-2166. PubMed ID: 29943426 [TBL] [Abstract][Full Text] [Related]
13. Enzymes involved in the metabolism of the carcinogen 2-nitroanisole: evidence for its oxidative detoxication by human cytochromes P450. Miksanová M; Sulc M; Rýdlová H; Schmeiser HH; Frei E; Stiborová M Chem Res Toxicol; 2004 May; 17(5):663-71. PubMed ID: 15144223 [TBL] [Abstract][Full Text] [Related]
14. Microsomal oxidation of N,N-diethylformamide and its effect on P450-dependent monooxygenases in rat liver. Amato G; Longo V; Mazzaccaro A; Gervasi PG Chem Res Toxicol; 1996; 9(5):882-90. PubMed ID: 8828925 [TBL] [Abstract][Full Text] [Related]
15. Characterization of the cytochrome P450 enzymes and enzyme kinetic parameters for metabolism of BVT.2938 using different in vitro systems. Baranczewski P; Edlund PO; Postlind H J Pharm Biomed Anal; 2006 Mar; 40(5):1121-30. PubMed ID: 16307862 [TBL] [Abstract][Full Text] [Related]
16. Individuality in cytochrome P450 expression and its association with the nephrotoxic and carcinogenic effects of chemicals. Wolf CR IARC Sci Publ; 1991; (115):281-7. PubMed ID: 1820342 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of recombinant cytochrome P450 enzymes as an in vitro system for metabolic clearance predictions. Stringer RA; Strain-Damerell C; Nicklin P; Houston JB Drug Metab Dispos; 2009 May; 37(5):1025-34. PubMed ID: 19196847 [TBL] [Abstract][Full Text] [Related]
18. Amine oxidases and monooxygenases in the in vivo metabolism of xenobiotic amines in humans: has the involvement of amine oxidases been neglected? Strolin Benedetti M; Tipton KF; Whomsley R Fundam Clin Pharmacol; 2007 Oct; 21(5):467-80. PubMed ID: 17868200 [TBL] [Abstract][Full Text] [Related]
19. Probing the world of cytochrome P450 enzymes. Frye RF Mol Interv; 2004 Jun; 4(3):157-62. PubMed ID: 15210869 [TBL] [Abstract][Full Text] [Related]